Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
-
Bio News | Breaking News | Clinical Trial Materials | Industry News
Emergent BioSolutions Wins $63M BARDA Contract
Will develop treatment for cyanide exposure together with Southwest Research Institute09.18.17
-
CRO News
PAREXEL Launches Real-World Data Service Offering
Aims to help drive value demonstration of new treatments09.06.17
-
Evolution of the CRO Project Manager
As clinical project managers become more strategic, more advanced technology must support their evolving rolesAndy Mehrotra, CEO, EightSpokes 08.31.17
-
Breaking News | Collaborations & Alliances | Industry News
BMS, Daiichi Sankyo Enter Research Collaboration
Will evaluate Opdivo and DS-8201 in HER2-expressing breast and bladder cancers08.30.17
-
CRO News
-
Cancer Trials in the New Age of Drug Development
Insights into the rapid pace of new drug approvals and the implications for pharma/biopharma companiesOnline Exclusives08.21.17
-
Collaborations & Alliances
PAREXEL, Osaka Cancer Institute Form Clinical Alliance in Japan
Aims to drive greater efficiencies in support of clinical trials in oncology and hematology08.21.17
-
Trials & Filings
Regeneron Discontinues Suptavumab Development
Phase III study did not meet its primary endpoint of preventing RSV infections in infants08.14.17
-
Breaking News | Industry News
Mallinckrodt Buys InfaCare for $425M
Expands pediatric offerings; diversifies hospital portfolio pipeline with differentiated, highly durable product08.07.17
-
Breaking News | Collaborations & Alliances | Industry News
BMS and Clovis Oncology Enter Clinical Collaboration
Will evaluate combination of Opdivo and Rubraca in Phase 2 and pivotal Phase 3 clinical trials in multiple tumor types08.03.17
-
Breaking News | Industry News
NeuroDerm Bought for $1.1B
Mitsubishi Tanabe Pharma Corporation acquires lead Phase III Parkinson’s candidate08.01.17
-
CRO News
-
CRO Competition Heats Up: Differentiate Offerings to Retain Site Loyalty
Site centricity becomes even more critical with increased CRO competition and M&ADave Espenshade, Vice President of CRO Partnerships, Greenphire 07.25.17
-
Breaking News | Industry News
Catalent Launches New OptiForm Solution Suite
Designed to offer easier path from late-stage discovery to phase I clinical trials07.17.17
-
Collaborations & Alliances
PDS, Merck Enter Keytruda Clinical Combo Alliance
Will evaluate PDS' Versamune-based immunotherapy with Merck's Keytruda in head and neck cancer and HPV16 infection07.10.17
-
Collaborations & Alliances
Lilly, Purdue Enter Five-year, $52M Strategic Alliance
Aims to develop improved delivery of injectable medicines and predictive models for clinical success07.06.17
-
CRO News
INC Research Expands Catalyst Program
Psychiatry Catalyst Site Network aims to enhance patient focus and optimize study delivery07.06.17
-
CRO News
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cell Medica Expands Immunotherapy Portfolio
Acquires WT1 cancer immunotherapy from Cell and Gene Therapy Catapult06.26.17
